# Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease

> **NCT00567177** · PHASE4 · COMPLETED · sponsor: **Innovative Medical** · enrollment: 40 (estimated)

## Conditions studied

- Treatment of Dry Eye Disease

## Interventions

- **DRUG:** Restasis, Refresh Plus

## Key facts

- **NCT ID:** NCT00567177
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567177, "Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00567177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*